ClinicalTrials.gg
CompletedNCT05664984Updated Dec 27, 2022

Effectiveness of Cognitive Rehabilitation for Amnestic Mild Cognitive Impairment

An interventional study of 1-face-to-face and 2-tele rehabilitation in Mild Cognitive Impairment and Cognitive Impairment, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-12-27.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Mar 2021, registered Dec 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
65 Years to 75 Years
Sex
All
01

Study summary

Different cognitive rehabilitation intervention methods have been developed for the treatment of cognitive dysfunctions seen in mild cognitive impairment (MCI). The aim of this study was to examine the effectiveness of cognitive rehabilitation intervention applied with the telerehabilitation method in elderly patients with amnestic-MCI.

Participants included in the study according to inclusion and exclusion criteria were randomly assigned to the telerehabilitation and face-to-face groups. A 12-week cognitive rehabilitation intervention was applied to both groups. Pre- and post-intervention cognitive skills of the participants were evaluated using the Loewenstein Occupational Therapy Cognitive Assessment-Geriatric (LOTCA-G).

Read the detailed description

A single-blinded, feasibility randomized controlled trial (RCT) investigated changes in the cognitive functions of older adults with amnestic-MCI after CR interventions applied face-to-face and with telerehabilitation. The study was designed according to the CONSORT statement. Approval for the study was granted by the Local Ethics Committee. Written informed consent was obtained from all participants prior to the study.

The demographic characteristics of the participants were recorded, including age, sex, education level, and marital status. All participants underwent a cognitive function assessment using the Loewenstein Occupational Therapy Cognitive Assessment-Geriatric twice, once before the intervention and again after the 12-week intervention. All participants were assessed in occupational therapy clinical practice units.

Participants were randomized to either the Face-to-Face group (FF) or the Tele-rehabilitation group (TR) using a computer-generated randomization technique.

After the randomization, cognitive rehabilitation intervention for both methods consist of 45-minute twice a week for 12 weeks. All participants received the intervention individually.

02

Conditions studied

  • Mild Cognitive Impairment
  • Cognitive Impairment
03

In context

Cognitive Dysfunction

3,932 studies on the registry are indexed under Cognitive Dysfunction; 1,114 are open to participants now.

This study's enrollment of 68 is close to the median of 64 across 2,855 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Saglik Bilimleri Universitesi is the lead sponsor of 447 studies on the registry; 138 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 65 and 75 years
  • Diagnosed with amnestic-MCI by medical doctors
  • Access to technological equipment; and
  • Ability to understand and follow verbal instructions.

Exclusion criteria

Exclusion Criteria:

  • Secondary chronic disease that may affect cognitive functioning;
  • Auditory and visual problems that may affect rehabilitation implementation and communication; and
  • Attendance of any rehabilitation program (physiotherapy, speech therapy, psychotherapy, etc.) during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (actual)

Study arms

  • Experimental
    1-face-to-face group

    Cognitive rehabilitation intervention was given face-to-face.

    Behavioral: 1-face-to-face

  • Experimental
    2-tele rehabilitation group

    Cognitive rehabilitation intervention was given tele-rehabilitation method.

    Behavioral: 2-tele rehabilitation

Interventions

  • Behavioral1-face-to-face

    The cognitive rehabilitation intervention consists of 45-minute sessions, 2 days a week for 12 weeks. The same rehabilitation intervention program was applied to both groups by face-to-face or tele-rehabilitation method. The main purpose of the study is to see the effectiveness of cognitive rehabilitation intervention in the elderly with amnestic mild cognitive impairment and to compare the two methods.

    Also known as: Cognitive rehabilitation

  • Behavioral2-tele rehabilitation

    2-tele rehabilitation

    Also known as: Cognitive rehabilitation

06

What researchers measure

Primary outcomes

  1. The Loewenstein Occupational Therapy Cognitive Assessment-Geriatric (LOTCA-G)

    The LOTCA-G, which was created to evaluate cognitive functions in the elderly. This test evaluates 8 cognitive domains with 24 items: orientation, visual perception, spatial perception, motor praxis, visuomotor organization, thinking operations, attention/concentration, and memory. The items in each subtest are evaluated on an ordered scale from 1 to 4 (excluding the orientation items scored from 1 to 8). A higher test score indicates better cognitive performance. The LOTCA-G can differentiate healthy older adults from those with dementia and MCI. It is sensitive to dementia levels and identifies changes over time. The LOTCA-G was used to evaluate the effectiveness of cognitive rehabilitation intervention both face-to-face and with tele-rehabilitation method. It was planned to evaluate the effectiveness of the intervention, which consisted of a total of 24 sessions of 12 weeks, by making a total of two evaluations before and after the treatment.

    Time frame: before the first session

  2. The Loewenstein Occupational Therapy Cognitive Assessment-Geriatric (LOTCA-G)

    The LOTCA-G, which was created to evaluate cognitive functions in the elderly. This test evaluates 8 cognitive domains with 24 items: orientation, visual perception, spatial perception, motor praxis, visuomotor organization, thinking operations, attention/concentration, and memory. The items in each subtest are evaluated on an ordered scale from 1 to 4 (excluding the orientation items scored from 1 to 8). A higher test score indicates better cognitive performance. The LOTCA-G can differentiate healthy older adults from those with dementia and MCI. It is sensitive to dementia levels and identifies changes over time. The LOTCA-G was used to evaluate the effectiveness of cognitive rehabilitation intervention both face-to-face and with tele-rehabilitation method. It was planned to evaluate the effectiveness of the intervention, which consisted of a total of 24 sessions of 12 weeks, by making a total of two evaluations before and after the treatment.

    Time frame: after the 12-week intervention program

07

Study locations

1 site
  • University of Health Sciences Türkiye
    Ankara, Turkey (Türkiye)
08

References and documents

Publications

  • Torpil B, Pekcetin E, Pekcetin S. The effectiveness of cognitive rehabilitation intervention with the telerehabilitation method for amnestic mild cognitive impairment: A feasibility randomized controlled trial. J Telemed Telecare. 2025 Apr;31(3):320-327. doi: 10.1177/1357633X231189541. Epub 2023 Aug 3. PubMed 37537894 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Jul 2021, 4 months.

Of 1,439 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 51. This study's 4 months is below that.

Counting every sponsor, half of 1,512 studies reached it within 26 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2022
First posted
Dec 27, 2022
StartActual
Mar 1, 2021
Primary completionActual
Jul 1, 2021
CompletionActual
Aug 1, 2022
Last update
Dec 27, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05664984
Responsible party
Berkan Torpil, PhD (Associate professor, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Dec 27, 2022
Start date
Mar 1, 2021
Primary completion
Jul 1, 2021
Completion
Aug 1, 2022
Last update
Dec 27, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion